0

Journal Articles

in Cardiology
 21-40 of 1809 Articles
Research Letters |  April 17, 2013
Long-term Outcomes of Left Anterior Fascicular Block in the Absence of Overt Cardiovascular Disease
Mala C. Mandyam, BS; Elsayed Z. Soliman, MD; Susan R. Heckbert, MD, PhD; et al.
JAMA. 2013;309(15):1587-1588. doi:10.1001/jama.2013.2729.
Medical News and Perspectives |  April 17, 2013
Two Specialty Societies to Run Their Own Clinical Trial of Heart Valve Replacement
Mike Mitka, MSJ
JAMA. 2013;309(15):1575-1576. doi:10.1001/jama.2013.2789.
Original Contribution |  April 17, 2013
Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries:  The Prospective Urban Rural Epidemiology (PURE) Study
Koon Teo, MB, PhD; Scott Lear, PhD; Shofiqul Islam, MSc; et al.
JAMA. 2013;309(15):1613-1621. doi:10.1001/jama.2013.3519.
INCLUDES: , Supplemental Content
Preliminary Communication |  April 17, 2013
Effect of Shock Wave–Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure:  The CELLWAVE Randomized Clinical Trial
Birgit Assmus, MD; Dirk H. Walter, MD; Florian H. Seeger, MD; et al.
JAMA. 2013;309(15):1622-1631. doi:10.1001/jama.2013.3527.
INCLUDES: , Supplemental Content
JAMA Patient Page |  April 17, 2013 FREE
Aspirin Therapy
Janet M. Torpy, MD; Edward H. Livingston, MD
JAMA. 2013;309(15):1645. doi:10.1001/jama.2013.3866.
INCLUDES: , Supplemental Content
Viewpoint |  April 17, 2013
Combination Therapy to Prevent Cardiovascular Disease:  Slow Progress
Richard Smith, MB, ChB, MSc, FRCPE; Tara McCready, MBA, PhD; Salim Yusuf, DPhil, FRCPC, FRSC
JAMA. 2013;309(15):1595-1596. doi:10.1001/jama.2013.3180.
Viewpoint |  April 17, 2013
Strategies and Opportunities for Drug Development in Heart Failure
Javed Butler, MD, MPH; Gregg C. Fonarow, MD; Mihai Gheorghiade, MD
JAMA. 2013;309(15):1593-1594. doi:10.1001/jama.2013.1063.
Editorial |  April 10, 2013
Long QT Syndrome Susceptibility Mutations and Pregnancy Loss:  Another Piece of a Still Unfinished Puzzle?
Alan E. Guttmacher, MD; Catherine Y. Spong, MD; Marian Willinger, PhD
JAMA. 2013;309(14):1525-1526. doi:10.1001/jama.2013.3373.
Original Contribution |  April 10, 2013
Long QT Syndrome–Associated Mutations in Intrauterine Fetal Death
Lia Crotti, MD, PhD; David J. Tester, BS; Wendy M. White, MD; et al.
JAMA. 2013;309(14):1473-1482. doi:10.1001/jama.2013.3219.
INCLUDES: , Supplemental Content
Lab Reports |  April 03, 2013
Age-Dependent Heart Damage
Tracy Hampton, PhD
JAMA. 2013;309(13):1337. doi:10.1001/jama.2013.3157.
Original Contribution |  April 03, 2013
Mortality Rates for Medicare Beneficiaries Admitted to Critical Access and Non–Critical Access Hospitals, 2002-2010
Karen E. Joynt, MD, MPH; E. John Orav, PhD; Ashish K. Jha, MD, MPH
JAMA. 2013;309(13):1379-1387. doi:10.1001/jama.2013.2366.
INCLUDES: , Supplemental Content
JAMA Patient Page |  April 03, 2013 FREE
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
INCLUDES: , Supplemental Content
Editorial |  March 27, 2013 FREE
Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)
Steven E. Nissen, MD
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778.
Editorial |  March 27, 2013 FREE
Evaluation of the Trial to Assess Chelation Therapy (TACT):  The Scientific Process, Peer Review, and Editorial Scrutiny
Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA; Robert M. Golub, MD
JAMA. 2013;309(12):1291-1292. doi:10.1001/jama.2013.2761.
INCLUDES: , Supplemental Content
Original Contribution |  March 27, 2013
Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction:  The TACT Randomized Trial
Gervasio A. Lamas, MD; Christine Goertz, DC, PhD; Robin Boineau, MD, MA; et al.
JAMA. 2013;309(12):1241-1250. doi:10.1001/jama.2013.2107.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  March 27, 2013 FREE
CDC Grand Rounds: The Million Hearts Initiative
JAMA. 2013;309(12):1221-1223. doi:10.1001/jama.2013.221.
Original Contribution |  March 27, 2013
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction:  A Randomized Clinical Trial
Margaret M. Redfield, MD; Horng H. Chen, MD; Barry A. Borlaug, MD; et al.
JAMA. 2013;309(12):1268-1277. doi:10.1001/jama.2013.2024.
INCLUDES: , Supplemental Content
Original Contribution |  March 20, 2013
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure:  The ASTRONAUT Randomized Trial
Mihai Gheorghiade, MD; Michael Böhm, MD; Stephen J. Greene, MD; et al.
JAMA. 2013;309(11):1125-1135. doi:10.1001/jama.2013.1954.
INCLUDES: , Supplemental Content
Viewpoint |  March 20, 2013
Improving Cardiovascular Health:  A Balance Between Discovery and Delivery
William A. Zoghbi, MD; David R. Holmes, MD
JAMA. 2013;309(11):1117-1118. doi:10.1001/jama.2013.2416.
JAMA Clinical Challenge |  March 13, 2013 FREE
Chest Pain and an Angiographic Abnormality
Vijaya L. Rao, MD; Vibhav Rangarajan, MD
JAMA. 2013;309(10):1030-1031. doi:10.1001/jama.2013.1865.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
Somatic Symptoms in Patients With Coronary Heart Disease: Prevalence, Risk Factors, and Quality of Life
Sebastian Kohlmann, MSc; Benjamin Gierk, MSc; Melanie Hümmelgen, MD; et al.
JAMA Ophthalmology
Ophthalmic Molecular Genetics  |  June 13, 2013
Distinct Ocular Expression in Infants and Children With Down Syndrome in Cairo, Egypt:  Myopia and Heart Disease
Hanan H. Afifi, MD, PhD; Amira A. Abdel Azeem, MD; Hala T. El-Bassyouni, MD, PhD; et al.
JAMA Dermatology
Off-Center Fold  |  June 12, 2013
Rapidly Enlarging Nodule on the Scalp—Quiz Case
Whitney Pollard, DO; James Pehoushek, MD, MPH
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems